Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Mesotherapy can cause serious side effects like infections and skin reactions.

An elderly Chinese man lost all his hair after taking a new heart medication.

Taking too many vitamin and mineral supplements can cause serious health problems.

A new hair loss treatment combining minoxidil and cedrol improves hair growth and reduces side effects.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

PEVs effectively deliver minoxidil through skin.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

PEVs improve minoxidil skin penetration, increasing hair growth.

Voriconazole can cause serious side effects, especially in long-term use.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

A patient experienced permanent hair loss due to an allergic reaction to a corticosteroid injection.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Platelet-rich plasma (PRP) speeds up skin wound healing and has potential in medical and cosmetic uses.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Synthetic hair fibers for hair restoration were controversial in 2009 due to health risks and lack of support from the International Society of Hair Restoration.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.